STRYKER CORP
No SEC Form 4 filings for $SYK in the last 30 days.
See all $SYK insider activity →Wolfe Research downgraded Stryker (SYK) to Peer Perform, citing a difficult second-half outlook after a March cyber disruption and noting the June quarter did not fully catch up. Wolfe said Stryker’s guidance implies 54% of revenue in 2H. Wolfe upgraded Abbott (ABT) to Outperform with a $130 target, citing better 2027 catalysts.
Stryker (NYSE:SYK) reported Q2 results on July 30 with sales up 9.4% to $6.6B and EPS up 44.1% to $3.30. The company cited recovery from a prior cyber incident. It guided full-year organic net sales growth of 8.3% to 9.3% and adjusted EPS of $14.95 to $15.10, while the article highlights a large gap between reported and adjusted earnings.
Stryker (NYSE:SYK) said its board declared a quarterly cash dividend of $0.88 per share. The dividend is payable Oct. 30, 2026, to shareholders of record as of Sept. 30, 2026. The company noted this is up 4.8% from the prior year and unchanged from the previous quarter.
Over the past 7 days, alphai's AI scored 2 news stories mentioning SYK (STRYKER CORP). Coverage has skewed bearish: 0 bullish, 1 neutral, and 1 bearish.
Recent SYK coverage spans financial news, market movers and earnings.
Near-term expectations are framed as harder to meet, with guidance implying a heavier 2H revenue burden.
The quarter looks strong on headline metrics, but the reported-versus-adjusted EPS gap highlights higher underlying costs and makes the sustainability of volume-driven growth the key debate.
Dividend increase is a modest, shareholder-return signal but not a fundamental earnings or guidance change.
Guidance narrowing plus margin expansion signals improving operating leverage after the prior cybersecurity incident, but peripheral vascular backorders remain a near-term risk.
The update is a sell-side valuation reset without new company fundamentals in the text.
alphai scores every news story that mentions SYK with an AI model for sentiment and relevance, and aggregates insider trades from STRYKER CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.
Wolfe Research downgraded Stryker (SYK) to Peer Perform, citing a difficult second-half outlook after a March cyber disruption and noting the June quarter did not fully catch up. Wolfe said Stryker’s guidance implies 54% of revenue in 2H. Wolfe upgraded Abbott (ABT) to Outperform with a $130 target, citing better 2027 catalysts.
2 min readStryker (NYSE:SYK) reported Q2 results on July 30 with sales up 9.4% to $6.6B and EPS up 44.1% to $3.30. The company cited recovery from a prior cyber incident. It guided full-year organic net sales growth of 8.3% to 9.3% and adjusted EPS of $14.95 to $15.10, while the article highlights a large gap between reported and adjusted earnings.
6 min readStryker (NYSE:SYK) said its board declared a quarterly cash dividend of $0.88 per share. The dividend is payable Oct. 30, 2026, to shareholders of record as of Sept. 30, 2026. The company noted this is up 4.8% from the prior year and unchanged from the previous quarter.
1 min readStryker (SYK) reported Q2 2026 adjusted EPS of $3.69, up 17.9% year over year, with organic net sales up 9% and adjusted gross margin at 66%. Management cited recovery from a prior cybersecurity incident and higher production. Full-year organic net sales guidance is 8.3% to 9.3%, and adjusted EPS guidance is $14.95 to $15.10.
6 min readUBS lowered its price target on Stryker (SYK) to $382 from $400 while keeping a Buy rating, according to the note cited in the article. The stock is shown trading around $341.20 at market close on Aug. 3, 2026.
1 min readSimply Wall St reports Stryker (NYSE:SYK) Q2 2026 results: sales of $6.6b and net income of $1.3b, with higher EPS from continuing operations. The stock fell 6.42% to $325.70 after results. The article cites a fair value of $386.80 (about 16% upside) but notes risks from European regulatory delays and supply chain issues.
4 min readSimply Wall St reports Stryker (SYK) released 2Q 2026 results with sales of $6.59b and net income of $1.28b. The stock fell 6.42% on the earnings day and is about 23% below one valuation estimate and 18% below the average analyst target. Consensus price target is $386.8, with a range from $465 to $315.
6 min readTipRanks highlights analyst rating changes for Intuit (INTU), Alphabet (GOOGL), Honeywell (HON), Becton Dickinson (BDX) and Stryker (SYK). Intuit was cut to Hold with a $304 target. Alphabet was upgraded to Buy, $425 target, after 2Q26 revenue +24% and cloud revenue +82%. Honeywell upgraded to Neutral, $265 target. BDX initiated Buy, $190 target. Stryker upgraded to Buy, $400 target.
4 min readStryker (SYK) shares fell about 6% to around $325 after its Q2 results. The company reported adjusted EPS of $3.69 and 9% organic sales growth. Adjusted gross margin was 66% and adjusted operating margin 27.4%. Q2 revenue rose to $6,589 million and guidance called for 8.3% to 9.3% organic growth and EPS $14.95 to $15.10.
5 min readStryker’s Q2 outlook update cites supply chain disruptions affecting growth, even as margins are expected to expand. Management says revenue acceleration depends on converting a backlog of capital equipment orders and improving peripheral vascular backorder recovery. Profitability may be pressured by cybersecurity remediation, higher production costs, and raw material volatility. Stryker shares were $321.25 after falling from $348.10 pre-earnings.
4 min read
